Intellectus Partners’s ProShares UltraShort Health Care RXD Stock Holding History

Intellectus Partners’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-55,875	Closed	-$134K	–	262
2020 Q4	$134K	Buy	55,875 +53,375	+2,135%	+$2.25M	0.04%	226
2020 Q3	$10K	Buy	+2,500	New	+$119K	﹤0.01%	206
2018 Q2	–	Sell	-2,500	Closed	-$28K	–	613
2018 Q1	$28K	Buy	+2,500	New	+$281K	0.01%	399

Other funds holding RXD

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Intellectus Partners's RXD Position: Q2 2021 in Review

Intellectus Partners sold out of ProShares UltraShort Health Care (RXD) in Q2 2021, closing a stake of 48,750 shares — an estimated $79K sold.

Intellectus Partners first reported a position in RXD in Q1 2021 and held it in 1 quarter. The position peaked at $79K in Q1 2021. 2 funds tracked by Wall St. Rank hold RXD as of Q2 2021.

Intellectus Partners reported no remaining ProShares UltraShort Health Care position as of Q2 2021 after selling out during the quarter.
Intellectus Partners sold 48,750 ProShares UltraShort Health Care shares in Q2 2021, an estimated $79K.
Intellectus Partners first reported a position in ProShares UltraShort Health Care in Q1 2021 and held it in 1 quarter.
Intellectus Partners's ProShares UltraShort Health Care position peaked at $79K in Q1 2021.
2 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q2 2021.

Based on Intellectus Partners's 13F filing for Q2 2021, filed 13 Aug 2021.